Purpose
Therapeutic Drug Monitoring
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80201
New York State Approval Status

Approved

Turnaround Time

4 days

Test Includes
1 Topiramate Topamax® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Anticonvulsant, Antiepileptic

Specimen Type
Fluid
Requested Volume
1 mL
Minimum Volume
0.3 mL
Special Handling
None
Specimen Container
Polycarbonate Plastic container

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 °C): Undetermined
1 Topiramate Topamax® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Anticonvulsant, Antiepileptic

Interface Map

LOINC® Information